{"nct_id":"NCT00985426","title":"Comparing Safety and Immunogenicity of HEPLISAV-B® to Engerix-B® in Chronic Kidney Disease (CKD) Patients","status":"COMPLETED","status_verified_date":"2021-04","start_date":"2009-09","start_date_type":null,"primary_completion_date":"2012-01","primary_completion_date_type":"ACTUAL","completion_date":"2012-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["DVAX"]}